Galson Steven K has filed 7 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 12500 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on June 12, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | A | Common Stock | 12500 | $0.00 | 70,871.0000 | 206,696,000 | 21.41% | 0.01% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | A | Automatic Stock Option Grant | 27181 | $0.00 | 27,181.0000 | 206,696,000 | 9999.99% | 0.01% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | A | Common Stock | 6820 | $0.00 | 58,371.0000 | 192,198,000 | 13.23% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| May 13, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | P | Common Stock | 21940 | $5.49 | 51,551.0000 | 192,198,000 | 74.09% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | A | Common Stock | 16745 | $0.00 | 29,611.0000 | 185,908,000 | 130.15% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Galson Steven K | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |